Health

Pfizer-BioNTech ask EU agency to OK vaccine for kids 5-11

Fitness & Health:

Pharmaceutical company Pfizer and biotechnology company BioNTech have requested to have their coronavirus vaccine licensed for children ages 5 to 11 across the European Union

Pfizer and BioNTech said they submitted data to the European Medicines Agency, including late-stage results from a study testing their COVID-19 vaccine in more than 2,200 children ages 6 months to 11 years. The children received a lower dose than what’s normally given to adults.

RELATED:  Older patients with heart failure denied effective treatments

Earlier this month, Pfizer and BioNTech asked the U.S. Food and Drug Administration to greenlight their vaccine for children ages 5 to 11.

Expanding vaccine availability to roughly 28 million more U.S. children was seen as another milestone in the fight against the virus and comes amid an alarming rise in serious infections in youngsters because of the extra-contagious delta variant.

In the United States, COVID-19 has killed at least 520 children so far, according to the American Academy of Pediatrics.

With much of Europe’s adult population already immunized, many countries are seeing increasing outbreaks of the disease in children while schools are mostly open and operating with sometimes patchy guidance on mask-wearing and social distancing.

DISCLAIMER:-If article is on fitness, health tips, beauty, tips-tricks care like recommendation, then check for DISCLAIMER in T&C.

Health News Today & Latest Medical News More Updates

Today News || Latest News || World News || US Politics || Health News || Technology News || Education News

Source

Tags
Show More

Related Articles

Back to top button
Close